Skye Bioscience
SKYE
58 hedge funds and large institutions have $78.1M invested in Skye Bioscience in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 20 reducing their positions, and 14 closing their positions.
1,849% more call options, than puts
Call options by funds: $2.32M | Put options by funds: $119K
0% more funds holding
Funds holding: 58 → 58 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
1.7% less ownership
Funds ownership: 65.86% → 64.16% (-1.7%)
8% less capital invested
Capital invested by funds: $85.3M → $78.1M (-$7.13M)
65% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$556K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$401K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$337K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$169K |
| 5 |
Two Sigma Investments
New York
|
+$110K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
5VM
5AM Venture Management
San Francisco,
California
|
-$874K |
| 2 |
FAM
Fred Alger Management
New York
|
-$842K |
| 3 |
BlackRock
New York
|
-$501K |
| 4 |
Millennium Management
New York
|
-$258K |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$227K |
SKYE Hedge Fund Activity: Q3 2025 in Review
58 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Skye Bioscience (SKYE) for Q3 2025, worth a combined $78.1M — down 8.4% from $85.3M a quarter earlier.
Fund positioning in SKYE was balanced in Q3 2025: 14 funds opened new positions, 14 closed out, 7 added to existing stakes and 20 trimmed.
The largest buyer was Marshall Wace, adding an estimated $556K. The largest seller was 5AM Venture Management, cutting an estimated $874K.
- 58 institutional investors held Skye Bioscience (SKYE) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $78.1M of Skye Bioscience stock for Q3 2025, down 8.4% quarter-over-quarter.
- 14 funds opened new Skye Bioscience positions in Q3 2025 and 14 closed out, a net change of 0 holders.
- The largest Skye Bioscience buyer in Q3 2025 was Marshall Wace, an estimated $556K added.
- The largest Skye Bioscience seller in Q3 2025 was 5AM Venture Management, an estimated $874K sold.
Based on aggregated 13F filings for Q3 2025.